Completed OBSERVATIONAL NCT01083459

Impact of PCV on Disease and Colonization Among Native American Communities

Sponsor: Centers for Disease Control and Prevention

Conditions Invasive Pneumococcal Disease Pneumococcal Nasopharyngeal Colonization

Updated 11 times since 2017 Last updated: Jan 16, 2015 Started: Jan 31, 2010 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Invasive Pneumococcal Disease and Pneumococcal Nasopharyngeal Colonization and is currently completed. Centers for Disease Control and Prevention leads this study, which shows 11 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Feb 2017 — Aug 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Johns Hopkins Bloomberg School of Public Health
National Institutes of Health (NIH)
Pfizer

Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gallup, United States
• Whiteriver, United States